Percutaneous procedures for deep vein thrombosis
LONDON, July 6, 2017 /PRNewswire/ -- Report presents summary of reimbursement situation for several procedures for treatment of deep vein thrombosis of lower extremities.
Procedures, included into analysis include:
Mechanical thrombectomy
Systemic thrombolysis
Catheter-directed thrombolysis
Ultrasound-enhanced catheter-directed thrombolysis
The following clinical situations are considered:
Stand-alone procedure, performed as primary procedure due to admission due to deep vein thrombosis
Procedure, performed as secondary procedure for DVT, developed during hospital admission for coronary artery bypass grafting or hip replacement
Analysis is performed for CABG and hip replacement
With no complications
With DVT and no interventional treatment
With DVT and interventional treatment
Analysis is performed only for non-elective hospital admission with at least an overnight stay.
Report includes essential information about reimbursement and national funding of the percutaneous procedures, including:
Brief overview of reimbursement system for medical devices
Procedure coding for technology
Diagnosis coding
Payment mechanism for technology
Reimbursement tariffs for technology
Restrictions in indications or scenarios for use of technology
Policy considerations by payers and policy-makers about technology
Reimbursement information is provided for the following geographies:
Austria
Belgium
Denmark
England (UK)
France
Germany
Italy
Netherlands
Norway
Sweden
Switzerland
Download the full report: https://www.reportbuyer.com/product/4941157/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Share this article